Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 3
2008 3
2010 1
2016 1
2017 2
2018 1
2019 1
2021 3
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial.
Richardson PG, Oriol A, Beksac M, Liberati AM, Galli M, Schjesvold F, Lindsay J, Weisel K, White D, Facon T, San Miguel J, Sunami K, O'Gorman P, Sonneveld P, Robak P, Semochkin S, Schey S, Yu X, Doerr T, Bensmaine A, Biyukov T, Peluso T, Zaki M, Anderson K, Dimopoulos M; OPTIMISMM trial investigators. Richardson PG, et al. Lancet Oncol. 2019 Jun;20(6):781-794. doi: 10.1016/S1470-2045(19)30152-4. Epub 2019 May 13. Lancet Oncol. 2019. PMID: 31097405 Clinical Trial.
Therapeutic landscape of advanced HER2-positive breast cancer in 2022.
Gupta R, Gupta S, Antonios B, Ghimire B, Jindal V, Deol J, Gaikazian S, Huben M, Anderson J, Stender M, Jaiyesimi I. Gupta R, et al. Among authors: huben m. Med Oncol. 2022 Oct 12;39(12):258. doi: 10.1007/s12032-022-01849-y. Med Oncol. 2022. PMID: 36224475 Review.
Occurrence of brominated disinfection by-products in thermal spas.
Usman M, Hüben M, Kato T, Zwiener C, Wintgens T, Linnemann V. Usman M, et al. Among authors: huben m. Sci Total Environ. 2022 Nov 1;845:157338. doi: 10.1016/j.scitotenv.2022.157338. Epub 2022 Jul 14. Sci Total Environ. 2022. PMID: 35843322 Free article.
Coronavirus Disease 2019 and Cold Agglutinin Syndrome: An Interesting Case.
Gupta R, Singh S, Anusim N, Gupta S, Gupta S, Huben M, Howard G, Jaiyesimi I. Gupta R, et al. Among authors: huben m. Eur J Case Rep Intern Med. 2021 Mar 10;8(3):002387. doi: 10.12890/2021_002387. eCollection 2021. Eur J Case Rep Intern Med. 2021. PMID: 33987115 Free PMC article.
NUT midline lung cancer: a rare case report with literature review.
Gupta R, Mumaw D, Antonios B, Anusim N, Dhulipalla SP, Stender M, Huben M, Jaiyesimi I. Gupta R, et al. Among authors: huben m. AME Case Rep. 2022 Jan 25;6:2. doi: 10.21037/acr-21-35. eCollection 2022. AME Case Rep. 2022. PMID: 35128310 Free PMC article.
Systematic Design of Adenosine Analogs as Inhibitors of a Clostridioides difficile-Specific DNA Adenine Methyltransferase Required for Normal Sporulation and Persistence.
Zhou J, Horton JR, Menna M, Fiorentino F, Ren R, Yu D, Hajian T, Vedadi M, Mazzoccanti G, Ciogli A, Weinhold E, Hüben M, Blumenthal RM, Zhang X, Mai A, Rotili D, Cheng X. Zhou J, et al. Among authors: huben m. J Med Chem. 2023 Jan 12;66(1):934-950. doi: 10.1021/acs.jmedchem.2c01789. Epub 2022 Dec 29. J Med Chem. 2023. PMID: 36581322 Free PMC article.
Reply to S.E. Langabeer.
Ogunleye F, Huang J, Ibrahim M, Allen E, Brennan N, Yu Z, Huben M, Jaiyesimi I. Ogunleye F, et al. Among authors: huben m. J Oncol Pract. 2017 Apr;13(4):285-286. doi: 10.1200/JOP.2016.020297. Epub 2017 Feb 14. J Oncol Pract. 2017. PMID: 28195810 No abstract available.
17 results